Cardiovascular Effects of Donepezil in Patients with Dementia
- 1 March 2003
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 15 (4) , 183-188
- https://doi.org/10.1159/000068781
Abstract
Heart rate variability is used to assess cardiovascular autonomic function. The cholinesterase inhibitor donepezil potentially affects parasympathetic activity. Twenty participants with Alzheimer’s disease or dementia with Lewy bodies were treated with donepezil in a pilot study. Power spectral analysis was used to analyse 5 min of beat-to-beat RR interval data in 15 cases. Heart rate variability was significantly reduced following treatment with donepezil; mainly for high frequency (median changed from 581 to 78 ms2; p = 0.001) but also for total power (median changed from 1,563 to 844 ms2; p = 0.047). Donepezil may adversely influence cardiovascular autonomic control. These results indicate the need for larger controlled trials to further investigate the cardiovascular effects of donepezil.Keywords
This publication has 5 references indexed in Scilit:
- The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1Dementia and Geriatric Cognitive Disorders, 1999
- The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998
- CorrespondenceJournal of the Neurological Sciences, 1996
- Cardiovascular Control by Cholinergic Mechanisms in the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1982